DENTSPLY SIRONA Inc. Down 4.99% To $30.59 After Earnings Miss

DENTSPLY SIRONA Inc (XRAY) missed earnings estimates for Q3 2022 this morning.

The consensus among analysts for DENTSPLY SIRONA Inc. was for an earnings per share (EPS) of $0.59. The firm failed to meet those projections, reporting an EPS of $0.41, a negative surprise of $0.18 (-31%). Profits fell 32% year-over-year after reporting an EPS of $0.60 in its year-ago quarter. The negative growth rate signals that the Healthcare company isn't performing well amid current economic conditions.

Revenues were downbeat at $947 million. That represents a 8.94% decrease in revenues from the year-ago report and is 8.06% lower than consensus estimates set at $1 billion.

The stock is down 4.99% to $30.59 after the report.

DENTSPLY SIRONA Inc.'s profit margins took a hit as earnings fell at a faster pace than revenues.

The average recommendation from Wall Street analysts was a Buy which may get revised based on this new data.

InvestorsObserver gives the stock a Bullish Sentiment score at the moment based on recent trading.

DENTSPLY SIRONA Inc. has performed a little below average during the past few months. Before the report, DENTSPLY SIRONA Inc. received a Long-Term Technical Rank by InvestorsObserver of 47, putting it in the bottom half of stocks. The firm was recently trading at a 52-week low of $26.48 on November 3, 2022 and set a 52-week high on February 25, 2022 at $58.7.

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters; and Consumables segment is responsible for the design, manufacture, sales, and distribution of dental consumable products which include categories of preventive, restorative, endodontic, and dental laboratory application. The majority of its products are sold through dental distributors, and over half of its sales are outside the U.S.